RecallDepth
Class III Terminated

Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and one 10-mL oral dosing syringe, Rx Only, Mfd for: ViiV Healthcare Durham, NC, 27701, By: GlaxoSmithKline Durham, NC 27701, NDC 49702-255-37

Company
Glaxosmithkline, Llc.
Recall Initiated
May 17, 2024
Posted
June 12, 2024
Recall Number
D-0544-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
463 Cartons
Firm Location
Zebulon, NC, United States

Reason for Recall

Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: AG4M, Labeled Expiry date on carton May 2026, correct Exp. Date 04/2025

More recalls by Glaxosmithkline, Llc.

View all recalls by this company →

Other recent Class III Drug recalls